Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Interactive Journal of Medical Research

Date Submitted: Aug 17, 2020
Date Accepted: Oct 2, 2020

The final, peer-reviewed published version of this preprint can be found here:

Carotid Endarterectomy Versus Carotid Artery Stenting: Survey of the Quality, Readability, and Treatment Preference of Carotid Artery Disease Websites

Strauss S, Yacob M, Bhandari A, Jetty P

Carotid Endarterectomy Versus Carotid Artery Stenting: Survey of the Quality, Readability, and Treatment Preference of Carotid Artery Disease Websites

Interact J Med Res 2020;9(4):e23519

DOI: 10.2196/23519

PMID: 33141097

PMCID: 7671836

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

CEA vs CAS: Assessing the quality, readability, and treatment preference of carotid artery disease websites

  • Shira Strauss; 
  • Michael Yacob; 
  • Apoorva Bhandari; 
  • Prasad Jetty

ABSTRACT

Background:

The internet is becoming increasingly more important in the new era of patient self-education. Carotid Endarterectomy (CEA) and Carotid Stenting (CAS) are both recognized interventions to treat patients with carotid artery stenosis. Using Google.com as a search platform, patients encounter a myriad of websites which have conflicting information, which is sometimes difficult to understand. This creates uncertainty or bias towards interventions for carotid artery disease.

Objective:

To explore the quality, readability, and treatment preference of carotid artery disease (CAD) websites.

Methods:

10 CAD-related keywords were searched in Google Canada. Returned links were assessed for publication date, medical specialty and industry affiliation, presence of RCT data, differentiation by symptomatic status, and favoured treatment. Website quality and readability were rated by the DISCERN instrument and Gunning Fog Index.

Results:

54 unique sites were identified. 18 (33.3%) were produced by medical societies or individual physicians, 11 (20.4%) by government organizations, nine (16.7%) by laypersons, and one (1.9%) was industry-sponsored. 26 sites (48.1%) distinguished symptomatic from asymptomatic CAD. A majority of sites overall (57.4%) and vascular-affiliated (72.7%) favoured CEA. In contrast, radiology- and cardiology-affiliated sites demonstrated the highest proportion of sites favoring CAS, though they were equally likely to favour CEA. A large proportion (38.9%) of sites received poor quality ratings (total DISCERN score<48), and the majority (75.9%) required a reading level greater than a high school senior.

Conclusions:

CAD websites are often produced by government organizations, medical societies, or physicians, especially vascular surgeons. Sites ranged in quality, readability, and differentiation by symptomatic status. Google searches of CAD-related terms are more likely to yield sites favouring CEA. Future research should determine the extent of website influence on CAD patients’ treatment decisions.


 Citation

Please cite as:

Strauss S, Yacob M, Bhandari A, Jetty P

Carotid Endarterectomy Versus Carotid Artery Stenting: Survey of the Quality, Readability, and Treatment Preference of Carotid Artery Disease Websites

Interact J Med Res 2020;9(4):e23519

DOI: 10.2196/23519

PMID: 33141097

PMCID: 7671836

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.